65 results on '"Solomon Daniel H"'
Search Results
2. Changes in alcohol intake and serum urate changes: longitudinal analyses of annual medical examination database
3. Investigating the ability to adhere to cardiometabolic medications with different properties: a retrospective cohort study of >500 000 patients in the USA
4. Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial
5. Derivation and external validation of a risk score for clinically important declines in health and function among two longitudinal cohorts of women in the mid-life
6. Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study
7. Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis
8. Meaning of patient global assessment when joint counts are low in rheumatoid arthritis
9. Risk of cardiovascular events in patients having had acute calcium pyrophosphate crystal arthritis
10. Rheumatoid arthritis disease activity assessed by patient-reported outcomes and flow cytometry before and after an additional dose of COVID-19 vaccine
11. Exploring patient experiences coping with using multiple medications: a qualitative interview study
12. Prescription medications for sleep disturbances among midlife women during 2 years of follow-up: a SWAN retrospective cohort study
13. Improving rheumatoid arthritis comparative effectiveness research through causal inference principles: systematic review using a target trial emulation framework
14. Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study
15. Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation
16. Identification of monosodium urate crystal deposits in patients with asymptomatic hyperuricemia using dual-energy CT
17. Response to: ‘Effects of colchicine on risk of cardiovascular events among patients with gout: as evidence accrues, is it time for a randomized trial?’ by Giannopoulos and Deftereos
18. Potential confounding in colchicine and cardiovascular disease study
19. Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims
20. Risk of incident atrial fibrillation in gout: a cohort study
21. Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry
22. Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study
23. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study
24. The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
25. Response to: ‘Biologic discontinuation studies: a systematic review of methods’ by van der Maaset al
26. Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study
27. Biologic discontinuation studies: a systematic review of methods
28. The risk of atrial fibrillation in patients with rheumatoid arthritis
29. Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist
30. Incidence and predictors of secondary fibromyalgia in an early arthritis cohort
31. A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis
32. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort
33. Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
34. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis
35. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity
36. Gout risk in adults with pre-diabetes initiating metformin.
37. Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry study.
38. Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis.
39. Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims.
40. Risk of incident atrial fibrillation in gout: a cohort study.
41. Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study.
42. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study.
43. Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry.
44. The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor.
45. Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study.
46. The risk of atrial fibrillation in patients with rheumatoid arthritis.
47. Biologic discontinuation studies: a systematic review of methods.
48. Response to: 'Biologic discontinuation studies: a systematic review of methods' by van der Maas et al.
49. Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist.
50. Incidence and predictors of secondary fibromyalgia in an early arthritis cohort.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.